S. Pani

Current Status of Chikungunya in India

Ujwala J Shetty, S. Chattopadhyay, P. Mamidi, 2021, Frontiers in Microbiology.

Clinical, Virological, Immunological, and Genomic Characterization of Asymptomatic and Symptomatic Cases With SARS-CoV-2 Infection in India

S. Raghav, S. Chattopadhyay, S. Devadas, 2021, Frontiers in Cellular and Infection Microbiology.

Telmisartan restricts Chikungunya virus infection in vitro and in vivo through the AT1/ PPAR-γ/MAPKs pathways

A. Ray, S. Chattopadhyay, P. Mamidi, 2021 .

MBZM-N-IBT, a Novel Small Molecule, Restricts Chikungunya Virus Infection by Targeting nsP2 Protease Activity In Vitro, In Vivo, and Ex Vivo

S. Chattopadhyay, P. Mamidi, S. Chattopadhyay, 2022, Antimicrobial agents and chemotherapy.

Telmisartan restricts Chikungunya virus infection in vitro and in vivo through the AT1/PPAR-γ/MAPKs pathways.

S. Chattopadhyay, P. Mamidi, S. Chattopadhyay, 2021, Antimicrobial agents and chemotherapy.

Mutant p53-R273H mediates cancer cell survival and anoikis resistance through AKT-dependent suppression of BCL2-modifying factor (BMF)

F. Chung, R. Rosli, C. Leong, 2015, Cell Death and Disease.

Free radical-scavenging activities of Homalium species – An endangered medicinal plant of Eastern Ghats of India

A. K. Sahoo, A. Mahapatra, Ajay Kumar Mahapatra, 2015, Natural product research.

Cytokine profile, neutralisation potential and viral replication dynamics in sera of chikungunya patients in India: a cross-sectional study

Ujwala J Shetty, S. Chattopadhyay, S. Sunil, 2023, The Lancet regional health. Southeast Asia.